Apomorphine: all 38 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Apomorphine in Severe Brain-injured PatientsRecruitingNCT05213169Phase 2/3
- Motor Network PhysiologyRecruitingNCT04957095Not applicable
- A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)CompletedNCT03391882Phase 3Results posted
- A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" EpisodesCompletedNCT03292016Phase 2Results posted
- A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" EpisodesCompletedNCT03187301Phase 2Results posted
- Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®TerminatedNCT02549573Phase 4Results posted
- Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseCompletedNCT02542696Phase 3Results posted
- Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's DiseaseCompletedNCT02469090Phase 3Results posted
- A Study to Examine APL-130277 in Patients With Parkinson's DiseaseCompletedNCT02228590Phase 2Results posted
- Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's DiseaseCompletedNCT02006121Phase 3Results posted
- Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)CompletedNCT01770145Phase 4Results posted
- Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's DiseaseCompletedNCT04887467Phase 4
- Apomorphine Effects on Pain in Parkinson's DiseaseStatus unknownNCT04879134Phase 2/3
- Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French HospitalsCompletedNCT03693872Not applicable
- Treating Severe Brain-injured Patients With ApomorphineStatus unknownNCT03623828Phase 2
- The Effects of Apomorphine on Experimental and Clinical Pain in Patients With Chronic Radicular PainCompletedNCT02969629Phase 4
- Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's DiseaseCompletedNCT02940912Phase 4
- Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)CompletedNCT02864004Phase 3
- Apomorphine in Parkinson's Disease Patients With Visual HallucinationsStatus unknownNCT02702076Phase 2
- Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).TerminatedNCT02688465Phase 4
- Infusion of Apomorphine: Long-term Safety StudyActive, not recruitingNCT02339064Phase 3
- Treatment of Apomorphine-induced Skin Reactions: a Pilot StudyTerminatedNCT02230930Phase 2
- Apomorphine Effects on Experimental PainCompletedNCT01744964Early Phase 1
- Phase IIa Multicentre Study Investigating of VR040 in Parkinson's DiseaseCompletedNCT01693081Phase 2
- Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's DiseaseCompletedNCT01683292Phase 2
- Extended Long-Term Safety Study of KW-6500CompletedNCT01063621Phase 3
- Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500CompletedNCT01058291Phase 3
- Long-Term Safety Study of KW-6500 in Patients With Parkinson's DiseaseCompletedNCT00955318Phase 3
- Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain InjurySuspendedNCT00761228Phase 2
- Comparison of Continuous and Pulsatile Apomorphine in Parkinson's DiseaseWithdrawnNCT00758368Phase 2
- Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa TherapyCompletedNCT00610103Phase 2
- Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging StudyCompletedNCT00524914Not applicable
- Low Dose Apomorphine and ParkinsonismWithdrawnNCT00472355Phase 2
- Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)Status unknownNCT00437177Phase 2
- Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons DiseaseCompletedNCT00200525Phase 3
- Continued Efficacy of Apomorphine After Previous Exposure of at Least Three MonthsCompletedNCT00200512Phase 2/3
- A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.CompletedNCT00145171Phase 3
- Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's DiseaseCompletedNCT00142545Phase 3